Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Short-Term Debt issuances

Growth Metrics

Hypha Labs (FUNI) Shares Issued (2016 - 2024)

Hypha Labs filings provide 8 years of Shares Issued readings, the most recent being $100.0 for Q4 2024.

On a quarterly basis, Shares Issued changed N/A to $100.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $100.0, a N/A change, with the full-year FY2022 number at $55600.0, up 174.57% from a year prior.
Shares Issued hit $100.0 in Q4 2024 for Hypha Labs, down from $20250.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $20250.0 in Q4 2020 to a low of $100.0 in Q4 2024.